EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butchart, E. G.
Right arrow Articles by Breckenridge, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butchart, E. G.
Right arrow Articles by Breckenridge, I. M.

European Journal of Cardio-Thoracic Surgery, Vol 2, 72-81, Copyright © 1988 by European Association for Cardio-thoracic Surgery


ARTICLES

Anticoagulation variability between centres: implications for comparative prosthetic valve assessment

EG Butchart, PA Lewis, EN Kulatilake and IM Breckenridge
Department of Cardiac Surgery, University Hospital of Wales, Cardiff, UK.

One of the major determinants in the choice of a mechanical prosthetic valve is that valve's thromboembolic record but the thromboembolic (TE) rates may be substantially influenced by the levels of anticoagulation achieved. A detailed study of anticoagulation variability was undertaken in 834 patients who received one or more of a particular prosthesis (Medtronic-Hall) in one centre during a 7-year period from 1979 to 1987, but who attended 27 different anticoagulant clinics spread over a wide area. In addition, a questionnaire was sent to all 89 practising cardiac surgeons in the UK asking for their preferred range of International Normalised Ratio (INR) for patients with mechanical prosthetic valves. Both the local study (with 16,866 INR observations) and the national questionnaire (with a 53% response) revealed an enormous amount of variability. Median INR values (semi- interquartile range) varied from 2.2 to 3.9 (0.8-2.5) according to the anticoagulant clinic attended. The range of INR preferred by UK cardiac surgeons, but presumably not necessarily achieved, varied from 1.8-2.2 to 3.0-4.8, with 64% of surgeons preferring an INR less than 3.0. In comparison, standard US practice is to maintain prothrombin times equivalent to INR values of 4.0-5.0. Unless anticoagulant practice can be standardised internationally, comparison of TE complications between centres is meaningless, and casts doubt on the validity of TE rates quoted for particular prostheses, unless accompanied by a detailed analysis of anticoagulant control.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
A. Kulik, F. D. Rubens, P. S. Wells, C. Kearon, T. G. Mesana, J. van Berkom, and B.-K. Lam
Early Postoperative Anticoagulation After Mechanical Valve Replacement: A Systematic Review
Ann. Thorac. Surg., February 1, 2006; 81(2): 770 - 781.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. A Geelani, S. Singh, A. Verma, A. Nagesh, V. Betigeri, and M. Nigam
Anticoagulation in Patients with Mechanical Valves During Pregnancy
Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 30 - 33.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. A.M. Al-Lawati, M. Venkitraman, T. Al-Delaime, and J. Valliathu
Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation
Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 223 - 227.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. G. Butchart, N. Payne, H.-H. Li, K. Buchan, K. Mandana, and G. L. Grunkemeier
Better anticoagulation control improves survival after valve replacement
J. Thorac. Cardiovasc. Surg., April 1, 2002; 123(4): 715 - 723.
[Abstract] [Full Text]


Home page
Eur Heart J SupplHome page
M. Dahm, G. Hafner, H. Schinzel, E. Mayer, D. Prufer, and H. Oelert
Early antithrombotic management after valve replacement
Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q12 - Q15.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. G. Butchart, H.-H. Li, N. Payne, K. Buchan, and G. L. Grunkemeier
Twenty years' experience with the Medtronic Hall valve
J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1090 - 1100.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.